公开(公告)号：US20200078396A1

公开(公告)日：2020-03-12

申请号：US16468227

申请日：2017-12-08

Applicant: JFE MINERAL COMPANY, LTD.

Inventor： Yuko ECHIZENYA ,  Yoshimi NAKATA ,  Etsurou UDAGAWA ,  Osamu YAMAMOTO

IPC: A61K33/30 ,  A61P17/02 ,  A61L15/18 ,  A61L15/44 ,  C01G9/00

Abstract: Disclosed is an inorganic composition which is useful as a base for pharmaceuticals and has excellent stability, and a method for producing the inorganic composition. The inorganic composition contains at least one compound selected from the group consisting of zinc sulfate, zinc chloride, zinc carbonate, zinc hydroxide, and zinc oxide, and has a pH of 7.2 or higher but lower than 8.3. After a dissolution test of the inorganic composition performed by a stirring method, the amount of Zn2* ions released therefrom is 0.1 pg/m2 or larger. This inorganic composition has the excellent property of gradually releasing zinc ions which makes the inorganic composition usable as a base for pharmaceuticals.

公开(公告)号：US20180311277A1

公开(公告)日：2018-11-01

申请号：US15735634

申请日：2016-06-10

Applicant: JFE MINERAL COMPANY, LTD.

Inventor： Etsurou UDAGAWA ,  Yuko ECHIZENYA ,  Chisaki MIURA ,  Yoshimi NAKATA ,  Osamu YAMAMOTO

IPC: A61K33/30 ,  A61K8/27 ,  A61Q19/00 ,  A61P17/02

Abstract: Provided is a low-cost, easy-to-handle, effective therapeutic agent for wounds that is a therapeutic agent for skin wounds or rough skin that includes at least one selected from the group consisting of zinc chloride, zinc hydroxide, and zinc oxide and may include a pharmaceutically acceptable carrier.

公开(公告)号：US20200237814A1

公开(公告)日：2020-07-30

申请号：US16851862

申请日：2020-04-17

Applicant: JFE MINERAL COMPANY, LTD.

Inventor： Etsurou UDAGAWA ,  Yuko ECHIZENYA ,  Chisaki MIURA ,  Yoshimi NAKATA ,  Osamu YAMAMOTO

IPC: A61K33/30 ,  A61K8/27 ,  A61Q19/00 ,  A61L15/22 ,  A61P17/02

Abstract: Provided is a low-cost, easy-to-handle, effective therapeutic agent for wounds that is a therapeutic agent for skin wounds or rough skin that includes at least one selected from the group consisting of zinc chloride, zinc hydroxide, and zinc oxide and may include a pharmaceutically acceptable carrier.

公开(公告)号：US20200061109A1

公开(公告)日：2020-02-27

申请号：US16467852

申请日：2017-12-08

Applicant: JFE MINERAL COMPANY, LTD.

Inventor： Yoshimi NAKATA ,  Yuko ECHIZENYA ,  Etsurou UDAGAWA ,  Osamu YAMAMOTO

IPC: A61K33/30 ,  A61L15/18 ,  A61L15/44 ,  C01G9/04 ,  A61P17/02

Abstract: Provided are: zinc chloride hydroxide that is useful as a pharmaceutical ingredient, has excellent zinc ion sustained-releasbility when used as a pharmaceutical agent, and exhibits excellent stability as a pharmaceutical ingredient; and a production method therefor. Disclosed is zinc chloride hydroxide that can be used as a pharmaceutical ingredient, that has excellent zinc ion sustained-releasability, that includes at least one member selected from the group consisting of zinc chloride, zinc hydroxide, and zinc oxide.

公开(公告)号：US20180318343A1

公开(公告)日：2018-11-08

申请号：US15735640

申请日：2016-06-10

Applicant: JFE MINERAL COMPANY, LTD.

Inventor： Etsurou UDAGAWA ,  Yuko ECHIZENYA ,  Chisaki MIURA ,  Yoshimi NAKATA ,  Osamu YAMAMOTO

IPC: A61K33/30 ,  A61K9/70 ,  A61K8/27 ,  A61L15/22 ,  A61P17/02 ,  A61Q19/00

CPC classification number: A61K33/30 ,  A61K8/27 ,  A61K9/70 ,  A61K9/7007 ,  A61L15/22 ,  A61P17/02 ,  A61Q19/00

Abstract: Provided is a therapeutic agent for skin wounds or rough skin that includes at least one selected from the group consisting of zinc sulfate, zinc chloride, zinc carbonate, zinc hydroxide, and zinc oxide, may include a pharmaceutically acceptable carrier, and is effective in regenerating tissue.